Global Anatomic Pathology and Companion Diagnostics Markets Projected to Reach $14.5B and $11.6B by 2031

The Anatomic Pathology market is forecast to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, representing a compound annual growth rate (CAGR) of 10.2% over the period. North America led the market in 2025, with consumables accounting for the largest share (58.7%) and hospitals the biggest end‑user segment (54.9%).

The Companion Diagnostics market is projected to expand from USD 6.31 billion in 2026 to USD 11.57 billion by 2031, a CAGR of 12.9%. The assays, kits and reagents segment held 67.3% of the market in 2025, while North America contributed the largest regional share at 44.7%. Growth is driven by the adoption of precision medicine, targeted oncology therapies, and increasing use of PCR and next‑generation sequencing technologies.